FOLH1 and prostate cancer: This study also revealed that theranostics is an application primarily used in South Africa using [68Ga]Ga-DOTATATE paired with [177Lu]Lu-DOTATATE for neuroendocrine tumors and [68Ga]Ga-PSMA paired with [177Lu]Lu-PSMA or [225Ac]AC-PSMA for prostate cancer (24).